Hagenbuch B, Stieger B, Locher KP. Organic anion transporting polypeptides: pharmacology, toxicology, structure, and transport mechanisms. Pharmacol Rev. 2025;77(2):100023.

Article  CAS  PubMed  Google Scholar 

McFeely SJ, Ritchie TK, Yu J, Nordmark A, Levy RH, Ragueneau-Majlessi I. Identification and evaluation of clinical substrates of organic anion transporting polypeptides 1B1 and 1B3. Clin Transl Sci. 2019;12(4):379–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang X, Reynolds K, Madabushi R, Huang SM. Current perspective on residual knowledge gaps in the assessment of transporter-mediated drug interactions. Clin Pharmacol Ther. 2022;112(3):450–2.

Article  CAS  PubMed  Google Scholar 

International council for the harmonization of technical documents – ICH M12 guideline for drug interaction studies.

Varma MVS. Clinical relevance of organic anion transporting polypeptide 1B-mediated hepatic uptake for high-permeability drugs: a perspective. Clin Pharmacol Ther. 2022;112(3):446–9.

Article  CAS  PubMed  Google Scholar 

Varma MV, Steyn SJ, Allerton C, El-Kattan AF. Predicting clearance mechanism in drug discovery: Extended Clearance Classification System (ECCS). Pharm Res. 2015;32(12):3785–802.

Article  CAS  PubMed  Google Scholar 

Eng H, Bi YA, West MA, Ryu S, Yamaguchi E, Kosa RE, et al. Organic Anion-Transporting Polypeptide 1B1/1B3-mediated hepatic uptake determines the pharmacokinetics of large lipophilic acids: in vitro-in vivo evaluation in Cynomolgus monkey. J Pharmacol Exp Ther. 2021;377(1):169–80.

Article  CAS  PubMed  Google Scholar 

Varma MV, Kimoto E, Scialis R, Bi Y, Lin J, Eng H, et al. Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast. Clin Pharmacol Ther. 2017;101(3):406–15.

Article  CAS  PubMed  Google Scholar 

Chien HC, Colas C, Finke K, Springer S, Stoner L, Zur AA, et al. Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1). J Med Chem. 2018;61(16):7358–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lefevre CR, Le Vee M, Gaubert S, Jouan E, Bruyere A, Moreau C, et al. Substrate-dependent trans-stimulation of Organic Cation Transporter 2 activity. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms222312926.

Article  PubMed  PubMed Central  Google Scholar 

Ellawatty WEA, Masuo Y, Fujita KI, Yamazaki E, Ishida H, Arakawa H, et al. Organic cation transporter 1 is responsible for hepatocellular uptake of the tyrosine kinase inhibitor Pazopanib. Drug Metab Dispos. 2018;46(1):33–40.

Article  CAS  PubMed  Google Scholar 

Schnegelberger RD, Steiert B, Sandoval PJ, Hagenbuch B. Using a competitive counterflow assay to identify novel cationic substrates of OATP1B1 and OATP1B3. Front Physiol. 2022;13:969363.

Article  PubMed  PubMed Central  Google Scholar 

Drabison T, Boeckman M, Yang Y, Huang KM, de Bruijn P, Nepal MR, et al. Systematic evaluation of tyrosine kinase inhibitors as OATP1B1 substrates using a competitive counterflow screen. Cancer Res Commun. 2024;4(9):2489–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fardel O, Moreau A, Carteret J, Denizot C, Le Vee M, Parmentier Y. The competitive counterflow assay for identifying drugs transported by solute carriers: principle, applications, challenges/limits, and perspectives. Eur J Drug Metab Pharmacokinet. 2024;49(5):527–39.

Article  CAS  PubMed  Google Scholar 

Schafer AM, Bock T, Meyer Zu Schwabedissen HE. Establishment and validation of competitive counterflow as a method to detect substrates of the Organic Anion Transporting Polypeptide 2B1. Mol Pharm. 2018;15(12):5501–13.

Article  CAS  PubMed  Google Scholar 

Schafer AM, Potterat O, Seibert I, Fertig O, Meyer Zu Schwabedissen HE. Hyperforin-induced activation of the Pregnane X Receptor is influenced by the Organic Anion-Transporting Polypeptide 2B1. Mol Pharmacol. 2019;95(3):313–23.

Article  CAS  PubMed  Google Scholar 

Ungvari O, Bakos E, Kovacsics D, Ozvegy-Laczka C. The fluorescence-based competitive counterflow assay developed for organic anion transporting polypeptides 1A2, 1B1, 1B3 and 2B1 identifies pentamidine as a selective OATP1A2 substrate. FASEB J. 2023;37(11):e23223.

Article  CAS  PubMed  Google Scholar 

Harper JN, Wright SH. Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2. Am J Physiol Renal Physiol. 2013;304(1):F56-67.

Article  CAS  PubMed  Google Scholar 

Boxberger KH, Hagenbuch B, Lampe JN. Ligand-dependent modulation of hOCT1 transport reveals discrete ligand binding sites within the substrate translocation channel. Biochem Pharmacol. 2018;156:371–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burckhardt BC, Henjakovic M, Hagos Y, Burckhardt G. Differential interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with human organic anion transporters 1 and 3. J Pharmacol Exp Ther. 2017;362(3):450–8.

Article  CAS  PubMed  Google Scholar 

Meyer Zu Schwabedissen HE, Ferreira C, Schaefer AM, Oufir M, Seibert I, Hamburger M, et al. Thyroid hormones are transport substrates and transcriptional regulators of organic anion transporting polypeptide 2B1. Mol Pharmacol. 2018;94(1):700–12.

Article  Google Scholar 

Schafer AM, Gilgen PM, Spirgi C, Potterat O, Meyer Zu Schwabedissen HE. Constituents of Passiflora incarnata, but not of Valeriana officinalis, interact with the organic anion transporting polypeptides (OATP)2B1 and OATP1A2. Planta Med. 2022;88(2):152–62.

Article  CAS  PubMed  Google Scholar 

Bi YA, Jordan S, King-Ahmad A, West MA, Yamaguchi E, Ryu S, et al. Low molecular weight acids and OATP1B mediated hepatic clearance: in vitro and in vivo evaluation using novel hypoxia-inducible factor prolyl hydroxylase inhibitors (Dustats). Drug Metab Dispos. 2024. https://doi.org/10.1124/dmd.123.001630.

Article  PubMed  Google Scholar 

Kimoto E, Costales C, West MA, Bi YA, Vourvahis M, David Rodrigues A, et al. Biomarker-Informed Model-Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug-Drug Interactions. Clin Pharmacol Ther. 2022;111(2):404–15.

Article  CAS  PubMed  Google Scholar 

Kimoto E, Mathialagan S, Tylaska L, Niosi M, Lin J, Carlo AA, et al. Organic anion transporter 2-mediated hepatic uptake contributes to the clearance of high-permeability-low-molecular-weight acid and zwitterion drugs: Evaluation using 25 drugs. J Pharmacol Exp Ther. 2018;367(2):322–34.

Article  CAS  PubMed  Google Scholar 

Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, et al. Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. J Med Chem. 2012;55(10):4740–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma P, Butters CJ, Smith V, Elsby R, Surry D. Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins. Eur J Pharm Sci. 2012;47(1):244–55.

Article  CAS  PubMed  Google Scholar 

Bi YA, Costales C, Mathialagan S, West M, Eatemadpour S, Lazzaro S, et al. Quantitative contribution of six major transporters to the hepatic uptake of drugs: “SLC-phenotyping” using primary human hepatocytes. J Pharmacol Exp Ther. 2019;370(1):72–83.

Article  CAS  PubMed  Google Scholar 

Bi YA, Scialis RJ, Lazzaro S, Mathialagan S, Kimoto E, Keefer J, et al. Reliable rate measurements for active and passive hepatic uptake using plated human hepatocytes. AAPS J. 2017;19(3):787–96.

Article  CAS  PubMed  Google Scholar 

Bi YA, Lin J, Mathialagan S, Tylaska L, Callegari E, Rodrigues AD, et al. Role of hepatic organic anion transporter 2 in the pharmacokinetics of R- and S-Warfarin: in vitro studies and mechanistic evaluation. Mol Pharm. 2018;15(3):1284–95.

Article  CAS  PubMed